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Background: Depression has been reported to increase the risk of subsequently developing dementia, but
the nature of this relation remains to be elucidated. Depression can be a prodrome/manifestation of
dementia or an early risk factor, and the effect may differ according to depression subtypes. Our aim was
to study the association between early-onset depression and different depression subtypes, and the later
occurrence of dementia.
Methods: We conducted a cohort study including 322 subjects with depression, recruited between 1977
and 1984. A comparison cohort (non-exposed) was recruited retrospectively, to include 322 subjects
admitted at the same hospital for routine surgery (appendicectomy or cholecystectomy), at the same
period as the depressed cohort. Subjects were contacted again between 2009 and 2014, to assess their
dementia status. We computed the risk for dementia in subjects with early onset depression and
quantiﬁed the association between different depression subtypes (namely melancholic, anxious, and
psychotic) and dementia.
Results: The odds of dementia were increased by 2.90 times (95% C.I. 1.61–5.21; po0.0001) for the
depressed cohort when compared to the surgical cohort. When the analysis was restricted to patients
younger than 45 years old at baseline, the odds for dementia in the depressed cohort were also sig-
niﬁcantly higher when compared to the surgical cohort (8.53; 95% C.I. 2.40–30.16). In the multivariate
Cox analysis, subjects having depression with melancholic features had an increased risk for developing
dementia compared to those without melancholic features (HR¼3.64; 95% C.I. 1.78–11.26; p¼0.025).
Limitations: About 59% of the participants with depression and 53% of those non-exposed were lost
during follow up. The inclusion of biological biomarkers would strengthen the results. The sample in-
cluded a low number of bipolar patients.
Conclusions: These results support depression as an early risk factor for dementia. Depression with
melancholic features was found as an important risk factor for dementia, playing a main role in the
relation between these disorders.
& 2016 Elsevier B.V. All rights reserved.1. Introduction
As most dementing conditions are irreversible, and the avail-
able therapies have limited beneﬁcial effects, primary prevention
of cognitive decline is of paramount importance (Ritchie et al.,
2010; Norton et al., 2014). Among the several risk factors so far
identiﬁed, depression emerges as a potentially important targetInstitute of Molecular Medi-
49 028 Lisboa, Portugal.
ões do Couto).(Reitz et al., 2011), because is amenable to prevention, has a high
prevalence, and can be diagnosed inexpensively and treated ef-
fectively (Kupfer et al., 2012; Malhi et al., 2015).
Depression has been found to be a risk factor for dementia or
Alzheimer's dementia (AD) in several case-control (Cooper and
Holmes, 1998; Green et al., 2003) and cohort studies (DalForno
et al., 2005; Kessing and Nilsson, 2003; Saczynski et al., 2010; Irie
et al., 2008; Dotson et al., 2010; Byers and Yaffe, 2011), but not all
(Chen et al., 1999, 2008; Gatz et al., 2005; Brommelhoff et al.,
2009). The meta-analyses and reviews performed have conﬁrmed
this association in general, ﬁnding that depression approximately
doubles the risk for dementia (Jorm, 2001; Ownby et al., 2006;
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However, the nature of this relation remains poorly under-
stood. Two unsolved issues have been repeatedly raised (Byers and
Yaffe, 2011; Kessing, 2012). The ﬁrst is that depression, especially if
occurring after 60 years old (called late onset depression) or next
to the diagnosis of dementia, can be a prodrome/manifestation of a
dementing disorder, instead of an early risk factor. Depressive
symptoms are quite common in dementia, and depressive symp-
toms may arise from the anatomic lesions that are part of the
neuropathological changes of dementing disorders (Boland, 2000).
Case-control studies that do not take in account the time between
dementia and depression diagnosis, and cohort studies with a
short follow up, may not be able to distinguish between these two
situations. The few studies that speciﬁcally compared late-onset
depression with early-onset depression found discrepant results
(Green et al., 2003; Geerlings et al., 2008; Brommelhoff et al.,
2009; Lenoir et al., 2011; Almeida et al., 2016).
The second issue is the subtype of depression. The hetero-
geneity of depression has seldom been taken into account. A more
severe disorder (expressed by higher frequency, duration, and
severity of the depressive episodes) has been inconsistently as-
sociated with a higher risk for dementia (Kessing and Andersen,
2004; Geerlings et al., 2008; Kessing, 2012; Silva et al., 2013). Bi-
polar disorder has also been associated with a higher risk of de-
mentia. In the review and meta-analysis by Silva et al. (2013) the
majority of studies conﬁrmed the association in accordance with
subsequent published studies. Brodaty et al. (2003) explored the
role of comorbid anxiety in depression on the risk for dementia
and found no inﬂuence. On the other hand, the use of benzodia-
zepines has been reported to carry a higher risk (Billioti de Gage
et al., 2012). Psychotic symptoms have been associated with a
higher risk for cognitive deﬁcits only in bipolar patients (Martínez-
Arán et al., 2004). Few studies looked at the risk for dementia in
DSM5 or ICD10 deﬁned depression subtypes. DalForno et al.
(2005), in a community based study, performed an additional risk
analysis ﬁnding that a Center for Epidemiologic Study–Depression
(CES-D) sub-scale based on a cluster of negative affective symp-
toms, related to melancholic features, did not inﬂuence the global
risk for dementia. Different biological mechanisms underlying
these different depressive conditions can carry different risks for
dementia. Melancholic features, and to a lesser extent psychotic
symptoms, have been associated with more consistent biological
abnormalities and response to treatment (Brown, 2007; Parker
et al., 2013) when compared to their absence.
These unsolved issues – prodrome versus early risk factor and
the heterogeneity of depression – regarding the risk for dementia
in depressed patients, encouraged us to perform the current study.
The objectives were to assess the association between early-onset
depression and the long-term risk for dementia, and to analyze the
risk for dementia of different depression subtypes, controlling for
well known risk factors for dementia.2. Methodology
2.1. Study design
This study is based on two cohorts followed in average 25 years
for development of dementia. The exposed cohort (depression
cohort) comprised 325 patients from the Hospital de Santa Maria,
Lisbon, with the clinical diagnosis of depression, recruited be-
tween 1977 and 1984 in a taxonomic cluster analysis study of
depression (Paes de Sousa et al., 1980).
A surgical comparison cohort (non-exposed) was recruited
retrospectively, to include 325 subjects who were consecutively
admitted to Hospital de Santa Maria, Lisbon, for routine surgery(appendicectomy or cholecystectomy) at the same period as the
depressed cohort.
Participants were re-evaluated between 2009 and 2014, to es-
tablish the outcome - dementia status.
2.2. Baseline assessment
Data on demography, clinical history, and personal and family
history as part of routine clinical ﬁles were collected for both co-
horts. For the depressed cohort a comprehensive psychiatric and
psychological evaluation was performed.
2.2.1. Evaluations
2.2.1.1. Association for methodology and documentation in psychiatry
system (AMDP). The AMDP-System was created in Nuremberg in
1960 and has been widely used in Europe in 1970–1980. The
Psychopathology Scale contains 100 psychopathology items, in-
cluding symptoms and other clinical features, derived from classic
psychopathology studies from Jaspers, Bleuler, Schneider, and
others. It renders a very detailed and standardized evaluation,
including affective, behavioral, cognitive, psychotic, sensory, and
social dimensions of psychopathology (Busch et al., 1980; Paes de
Sousa et al., 1980).
Each symptom is scored for severity (0–3: absent, mild, mod-
erate, severe).
This evaluation notably allowed the classiﬁcation of depression
by virtually any diagnostic system and has been used for diag-
nostic or reclassiﬁcation purposes with other diagnostic systems,
such as the DSM IV (Salvatore et al., 2007; Seemüller et al., 2008).
2.2.1.2. Eysenck personality questionnaire (EPQ). This questionnaire
(Eysenck and Eysenck, 1975) includes 83 items (full version), al-
lowing the evaluation of the three basic personality dimensions,
according to Eysenck's personality theory: extroversion, neuroti-
cism and psychoticism. Only the extroversion and neuroticism
dimensions were analyzed in this study. The subject responds yes
or no, and a positive answer is scored 1. The ﬁnal result is the sum
of the points in each scale (0–23 for extroversion and 0–23 for
neuroticism).
The neuroticism dimension assesses emotional stability versus
instability and identiﬁes individuals prone to psychological dis-
tress. Low scores indicate a trend to more relaxed, unemotional,
and self-satisﬁed subjects. The extraversion dimension measures
interpersonal interaction, activity level, need for stimulation, and
capacity for joy. The subjects with a low score tend to be more
reserved, sober, task-oriented, and quiet.
A low extroversion (a score lower then median) and high
neuroticism group (a score higher than median) of subjects was
created, as these subjects were previously found to be at a higher
risk for dementia (Wang et al., 2009).
2.2.1.3. Clinical global impression (CGI)). Clinical global impression
– severity (CGI S; Guy, 1976) is 7-point scale to evaluate the current
severity of the patient's illness, according to the clinician's total
past experience, ranging from 1 (not at all ill) to 7 (extremely ill).
2.2.2. Diagnosis of depression
Using AMDP symptoms at baseline, DSM 5 diagnostic criteria
for Persistent Depressive Disorder (dysthymia), Major Depressive
Disorder (MDD), melancholic and psychotic features were applied.
Through baseline chart review, subjects were considered to have
bipolar disorder if they met DSM 5 criteria for bipolar disorder.
The speciﬁer of anxious distress could not be deﬁned by AMDP
as only two anxious symptoms (“psychic anxiety” and “somatic
anxiety”) are present in the scale. A numerical variable “anxiety
symptoms” was created adding both scores. Chronic disease was
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Fig. 1. Diagram displaying the ﬂow of subjects cases in the study. NHS National Health Service, FU Follow up. In 278 (43.2%) cohort subjects the diagnosis of dementia could
be established or excluded. The rates of follow up in relation to death are 42.7% in the exposed group and 60.0% in the non-exposed group.
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than two years.
2.3. Follow-up
2.3.1. Follow up procedures
The Hospital de Santa Maria, the Institute of Notaries and Re-
cords, and the National Health Service databases were contacted
to get the subjects' address and next of kin, phone number, vital
status, General Practitioner (GP) and other relevant doctors'
names. This search allowed to ﬁnd and contact subjects, or next of
kin if the subject was dead.
2.3.1.1. Depressed cohort. Based on the information gathered dur-
ing the follow-up, the initial diagnosis was reviewed and 3 pa-
tients were excluded from the depressed cohort because the di-
agnosis of depression was found wrong, namely one had schizo-
phrenia, another schizoaffective disorder and the third a brain
tumor. So, the depressed cohort recruited 322 subjects (Fig. 1).
It was not possible to ascertain the vital status of 123 subjects
(no records found, data illegible or too many records found for a
given name).
In the remaining 199 (61.2%), additional information wassought to establish a diagnosis of dementia. In the 75 subjects
found to be dead, the next of kin was contacted to collect demo-
graphic information and to apply the Dementia Questionnaire
(DQ). GP records, psychiatrist records, neurologist records, hospital
clinical ﬁles, death certiﬁcates and nursing home records were
reviewed to collect information regarding dementia diagnosis. In
43 subjects no contact with next of kin was possible or the clinical
information in clinical ﬁles was not enough to establish or exclude
the diagnosis of dementia.
The 124 alive subjects were contacted ﬁrst by mail, presenting
the study and indicating that a later phone contact would be done.
Then, a clinical interview and a neuropsychological assessment
were offered. If a subject was living far away, too ill to be sub-
mitted to neuropsychological assessment, or not willing to come
for the clinical/neuropsychological assessment, telephone inter-
views (Telephone Interview for Cognitive Status (TICS) and/or DQ)
to evaluate the cognitive status were applied. Patient's GPs, or
other relevant doctors were contacted, and hospital records re-
viewed when appropriate. No contact at all was possible and no
clinical records were found in 7 subjects, and a total of 16 subjects
refused to participate in the study. In 133 (41.3%) subjects the
outcome could be established (Fig. 1).
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the methodology of a similar study (Brodaty et al., 2003). The ﬁrst
325 subjects who were admitted for routine appendectomy or
cholecystectomy at the same period as cases, and who could be
matched to cases for age (72 years) and sex were identiﬁed from
surgical lists (Fig. 1). For each depressed subject, the ﬁrst identiﬁed
matched control in the surgical list was assessed for his/her elig-
ibility status. A subject was considered eligible if a mood disorder
was not present prior to or at the time of index surgical hospita-
lization. This assessment was made by the review of the subject
clinical ﬁles at the index hospitalization, and a diagnosis of a mood
disorder and prescription of antidepressants, mood stabilizers or
antipsychotics were considered exclusion criteria. A further as-
sessment was performed at follow up by direct questioning. Three
subjects were excluded from the surgical cohort, because they
were found to be depressed (n¼2) or to have a diagnosis of bipolar
disorder (n¼1) at inclusion time. The surgical (non-exposed) co-
hort included 322 subjects.
Identical procedures were taken to assess their dementia status
as with the depressed participants. It was possible to ascertain the
vital status of 128 subjects (60.2%). Among these, 5 refused to
participate in the study, and in 45 the diagnosis of dementia could
be not conﬁrmed or excluded. The diagnosis of dementia could be
established or excluded in 144 subjects (44,3%).
2.3.2. Follow up assessment (evaluations performed in 2009–2014)
2.3.2.1. Neuropsychological assessment. A comprehensive evalua-
tion was performed, either at patients' home or in the hospital, by
experienced neuropsychologists. The evaluation included (1) Bat-
tery of Lisbon for the Assessment of Dementia (BLAD; Garcia,
1984), (2) Trail Making Test – parts A and B (TMT; Reitan, 1958),
(3) Toulouse-Pie ́ron Test (TP; Toulouse and Pie ́ron, 1986; Men-
delsohn, 2000), and (4) California Verbal Learning Test (CVLT; Delis
et al., 1987; Ribeiro et al., 2007).
2.3.2.2. Other assessments
) Telephone Interview for Cognitive Status (TICS)
This instrument (Brandt et al., 1988; Madureira et al., 2006) was
initially developed for the assessment of AD patients unwilling
or unable to return for follow-up. It gathers information on the
domains of orientation, concentration, short-term memory,
mathematical skills, praxis and language. It was proven to be
sensitive and speciﬁc, and to have high test–retest reliability.
The cutoff used for dementia was less than 26.
) Dementia Questionnaire (DQ)
The Dementia Questionnaire (Silverman et al., 1986) is applied
by telephone to caregivers of patients with dementia allowing
to quickly diagnose dementia in patients by the DSM IIIR
criteria, and in some cases even to suggest the dementia
subtype. The DQ can also be applied to care givers of already
dead patients with dementia. A validated version including the
age of onset of dementia and dementia subtype was used
(Teixeira et al., 2011).
) Vascular risk factors assessment
Subjects with a previous diagnosis of hypertension, diabetes,
dyslipidemia, ischemic heart disease or cerebrovascular disease
were considered to have vascular risk factors.
2.3.3. Diagnosis of dementia
Dementia was diagnosed at a case conference, including a
psychiatrist (F.S.doC.), a neurologist (A.deM.) and a neu-
ropsychologist (C.C.), all experienced in dementia. Cases were
determined based on the best available information, using DSM-5
criteria for Major Neurocognitive Disorder (dementia) (AmericanPsychiatric Association, 2013).
Clinical and neuropsychological assessment information were
reviewed. If a subject was dead or did not attend the formal eva-
luation, case conference reviewed all the available evidence. In
these cases, the diagnosis of dementia was based on at least two of
the following: TICS score of 26 or less; DQ yielded a diagnosis of
dementia; GPs records with a diagnosis of dementia; a diagnosis of
dementia performed by either a neurologist or a psychiatrist;
hospital records of dementia; death certiﬁcate with a diagnosis of
dementia; retrospective case audit to meet DSM-5 dementia cri-
teria; diagnosis of dementia recorded in nursing-home notes. If a
diagnosis of dementia was established, reference to a Dementia
Clinics was offered to the subject, to undergo the standard of care
for evaluation and treatment of dementia.
The type of dementia was determined in the case conference
referred above, using all the available information. The criteria for
the diagnosis of the most common types of dementia were used:
probable Alzheimer's disease according to NINCDS-ADRDA criteria
(McKhann et al., 2011), probable vascular dementia according to
NINDS-AIREN criteria (Roman et al., 1993), probable dementia
with Lewy bodies (DLB) according to the criteria proposed by
McKeith et al. (2005), and behavioral variant of frontotemporal
dementia (FTD) according to the criteria of the International Be-
havioral Variant FTD Criteria Consortium (Rascovsky et al., 2011). If
none of these criteria was met, or no sufﬁcient information could
be gathered, the diagnosis made was dementia non-otherwise
speciﬁed (NOS). Date of onset of dementia was determined during
the clinical interview, by DQ, or chart review.
2.4. Statistical analysis
IBM SPSS Statistics for Windows, version 19.0 (IBM Corp, Ar-
monk, NY, 2010) and Stata Statistical Software: Release 11 (Stata-
Corp LP, College Station, TX, 2009) were used for the statistical
analysis.
Baseline characteristics were compared between subjects in
whom the outcome was assessed and in those lost during follow-
up, using independent samples t Student's test for continuous
variables, after veriﬁcation of homogeneity of variances, and
Pearson Chi-square test for categorical variables, with Yates con-
tinuity correction for 22 tables.
We used a binary logistic regression analysis (with the de-
pendent variable constituted by the conversion to dementia dur-
ing the follow-up period) to compute the odds ratio (OR) for the
associations between depression and dementia. Because data on
age of dementia onset in the non-exposed cohort were available
only in a minority of subjects, it was not possible to perform a Cox-
regression analysis in this group.
Cox proportional hazards models were used to compute crude
and adjusted hazard ratios (HR) and 95% conﬁdence intervals (95%
CI) to quantify the relation between the different exposures, in-
cluding depression subtypes, and dementia. For multivariate
analyses we considered the variables that were signiﬁcantly as-
sociated (po0.05) with dementia in univariate analysis (baseline
age, depression with melancholic features, depression with anxi-
ety symptoms, and severity of the index episode (CGI)), as well as
variables considered to be potentially relevant confounding factors
(sex, years of education, bipolar disorder, depression with psy-
chotic features, and chronic disorder), according to the literature
(Kessing and Andersen, 2004; Ritchie et al. 2010; Reitz et al., 2011;
Silva et al., 2013). Age of onset and the presence of vascular risk
factors were considered only in sensitivity analyses because data
on these variables was available for a subset of all patients (77 and
123, respectively), and due to the fact that the latter was assessed
at follow-up. For each participant the follow-up started at the date
of diagnosis of depression, or corresponding index data in the
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mentia, date of follow-up assessment or date of death, whichever
occurred ﬁrst, as applicable. The proportional hazards assumption
was evaluated graphically using “log-log” plots.
The cumulative incidence of dementia was estimated, across
the follow-up period, taking into account the competing risk of
death, using a competing-risks regression model, according to the
method of Fine and Gray (Fine and Gray, 1999).
Statistical signiﬁcance was accepted for po0.05.
2.5. Ethics
This study was conducted in accordance with the Helsinki
Declaration as well as national ethical guidelines. The local Ethics
Committee, the National Data Protection Committee, and the Na-
tional Institute of Notaries and Records approved the protocol.
Subjects who performed follow up evaluation were required to
provide informed consent. If a diagnosis of dementia was estab-
lished, reference to a Dementia Clinics was offered to the subject,
to undergo the standard of care for evaluation and treatment of
dementia.3. Results
Comparing baseline data of the subjects with and without a
known outcome, the mean age was lower in both cohorts, and the
proportion of men was smaller in the subjects with a known
outcome only in the depressed cohort. No statistically signiﬁcant
differences were observed regarding other socio-demographic and
clinical characteristics (Table 1). Almost all subjects were Cauca-
sian (98%).
3.1. Depression as a risk factor for dementia
Forty-four (22.3%) of the 133 subjects from the depressed co-
hort developed dementia, compared to 21 (14.6%) of the 144
subjects from de surgical cohort. Dementia cause could be as-
sessed in about half of the cases (in 21 and 8 subjects, depressed
and surgical respectively). The most prevalent cause in both
groups was Alzheimer's disease (AD) (57% and 63%), followed by
vascular dementia (19% and 25%), and Parkinson's disease (14%
only in the depressed cohort). Other causes, found only in one
patient each, were vitamin B12 deﬁciency and HIV dementia in the
depressed cohort and neurosyphilis in the surgical cohort.Table 1
Baseline characteristics of both cohort subjects to known outcome.
Depressive cohort
Lost during follow
up (n¼189)
With known out-
come (n¼133)
Total
(n¼322)
Age, mean (SD), y 50.8 (12.7)b 41.8 (11.6) 46.9 (13.0)
Male sex, % (n) 27.0% (51) 15.0% (20) 22.0% (71)
Education, mean (SD), y 6.4 (4.6) 7.1 (4.5) 6.7 (4.6)
Bipolar disorder, % (n) 10.6% (20) 16.5% (22) 13.0% (42)
Melancholic features, % (n) 33.3% (63) 35.3% (47) 34.2% (110)
Psychotic features, % (n) 24.3% (46) 24.1% (32) 24.2% (78)
Anxiety symptoms severity,
mean (SD)
1.6 (2.6) 1.9 (2.8) 1.7 (2.7)
Clinical Global Impression
(CGI), mean (SD)
5.0 (0.8) 5.0 (0.7) 5.1 (0.7)
N.A. not available. Education years were not written in most surgical ﬁles.
a Comparing, within each cohort, those with a known outcome with those without
samples t test for continuous variables.
b Baseline age available only for 182 subjects.
c Education years available for 111 subjects.The characteristics of subjects who developed dementia and
those that have not are displayed in Table 2. At follow-up 4 pa-
tients were rediagnosed as bipolar, due to a later emergence of a
manic episode, and 2 non bipolar patients fulﬁlled DSM5 criteria
for Persistent Depressive Disorder at baseline, but were re-classi-
ﬁed later as MDD.
A logistic binary regression analysis showed that the odds of
dementia were increased by 2.90 times (95% C.I. 1.61–5.21;
po0.0001) for the depressed cohort when compared to the sur-
gical cohort. The higher risk for dementia in the depressed cohort
was still signiﬁcant after adjusting for sex, age, and education
years (OR¼3.36; 95% C.I. 7.76–6.80; po0.0001).
3.2. Depression as an early risk factor
To address the issue of depression as a prodrome of dementia
we repeated the analysis considering the subjects with an early
onset of depression and those with a longer time frame between
the two diagnoses. The deﬁnition of the age limit of late onset
depression varies across the studies, between the age of 45
(Steffens et al., 1997) and the age of 60 years (Byers and Yaffe,
2011). When the analysis was restricted to patients younger than
45, or 60 years old at baseline, the odds for dementia in the de-
pressed cohort were still signiﬁcantly higher when compared to
the surgical cohort (8.53; 95% C.I. 2.40–30.16 and 3.30; 95% C.I.
1.75–6.33, for those younger than 45 and 60, respectively). When
adjusting for age, sex, and education years, similar results were
found (8.69; 95% C.I. 2.21–34.23 and 4.00; 95% C.I. 1.87–8.60, for
those younger than 45 and 60, respectively).
Age of depression onset was only available in 77 subjects. In
those with depression onset before the age of 60 the odds of de-
veloping dementia were not different for those with depression
onset after the age of 60 (0.84; 95% C.I. 0.38–1.84), even after
controlling for age, sex, and education years (0.72; 95% C.I. 0.30–
1.74).
A 10 years difference between depression diagnosis and de-
mentia onset has been used as a criterion to reduce the risk of
misdiagnosing depression as prodrome of dementia (Brunnström
et al., 2013). When restricting the analysis to the subjects with a
follow up time longer than 10 years (94.0% in the exposed group
and 97.9% in the non-exposed group), depression still emerged as a
risk factor for dementia when compared to the surgical cohort
(2.95; 95% C.I. 1.62–5.40 and 4.16; 95% C.I. 1.96–8.83, for crude and
adjusted OR, respectively).Surgical cohort
p Valuea Lost during follow
up (n¼178)
With known out-
come (n¼144)
Total
(n¼322)
p Valuea
o0.001 47.7 (14.5) 41.0 (12.1) 44.6 (13.8) o0.001
0.014 24.2% (43) 19.4% (28) 22.0 (71) 0.212
0.165 N.A. 6.63 (4.6)c
0.326
0.722
0.999
0.288
0.978
known outcome, based on chi-square test for category variables and independent
Table 2
Cohort characteristics and outcome.
Depressed cohort Surgical cohort
Non-demented (n¼89) Demented (n¼44) Non-demented (n¼123) Demented (n¼21)
Age, mean (SD), y 38.9 (10.4) 47.8 (11.5) 37.7 (11.0) 54.2 (9.1)
o35 years, % (n) 46.1% (41) 11.4% (5) 48.8% (60) 0.0%(0)
35–45 years, % (n) 23.6% (21) 29.5% (13) 22.8% (28) 14.3% (3)
445 years, % (n) 30.3% (27) 59.1% (26) 28.5% (35) 85.7% (18)
Male % (n) 14.6% (13) 15.9% (7) 19.5% (24) 19% (4)
Education, mean (SD), ya 7.8 (4.5) 5.9 (4.4) 7.3 (4.7) 2.9 (1.7)
o5 years, % (n) 39.3% (35) 61.4% (27) 48.4% (59) 85.7% (18)
5–9 years, % (n) 31.5% (28) 22.7% (10) 14.8% (18) 0.0% (0)
49 years, % (n) 29.2% (26) 15.9% (7) 36.9% (45) 14.3% (3)
Follow up time, mean (SD), y 26.3 (7.2) 24.5 (7.3) 29.0 (6.8) 25.1 (7.6)
Age of onset of the disorder, mean (SD), yb 28.4 (10.2) 34.8 (10.2)
Bipolar disorder, % (n) 14.6% (13) 18.2% (8)
DSM5 Diagnosed MDD, % (n) 84.3% (75) 79.5% (35)
Melancholic features, % (n) 24.7% (22) 56.8% (25)
Psychotic features, % (n) 20.2% (18) 31.8% (14)
Anxiety symptoms severity, mean (SD), AMDP score 1.48 (2.59) 2.86 (2.95)
Clinical Global Impression (CGI), mean (SD) 4.9 (0.7) 5.1 (0.7)
Chronic Disorder, % (n) 71.3% (57) 92.3% (36)
Inpatient at baseline, % (n) 55.1% (49) 65.9% (29)
Ever been admitted for depression, % (n)c 82.7% (62) 94.6% (35)
Suicide attempts, % (n)d 43.9% (25) 66.7% (12)
EPQ (Extroversion), mean (SD)e 38.0 (21.2) 35.1 (17.5)
EPQ (Neuroticism), mean (SD)e 81.8 (14.9) 78.8 (14.8)
High Neuroticism/Low Extroversion Group, % (n)e 24.6% (14) 23.3% (7)
Vascular risk factors, % (n)f 59.8% (52) 80.6% (29) 61.2% (63) 76.9% (10)
Age of dementia onset (y), mean (SD) 72.3 (8.8) 81.5 (8.5)
Died, % (n) 18.0% (16) 36.4% (16) 19.5% (24) 57.1% (12)
MDD Major Depressive Disorder, EPQ Eysenck Personality Questionnaire.
a Data available only in 111 controls.
b Data available only in 77 subjects.
c Data on admission status was available in 82 subjects.
d 58 subjects had suicide data.
e 87 subjects had baseline EPQ.
f Data obtained at follow up, available in 123 depressed and in 116 surgical subjects.
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In the depressed cohort, the probability of dementia increased
signiﬁcantly with age, was not inﬂuenced by education and was
signiﬁcantly higher for melancholic features, anxiety symptoms,
and severity of the episode assessed with the CGI, in the univariateTable 3
Depressed cohort: association between demographic variables, clinical characteristics a
Univariate analysis
HR (95% CI)
Baseline age, y
o35 1 [reference]
35–45 7.55 (2.15–26.52)
445 15.17 (4.55–50.58)
Baseline education, y
0-4 1 [reference]
5–9 0.88 (0.42–1.84)
49 0.47 (0.19–1.15)
Bipolar disorder 1.88 (0.86–4.14)
Melancholic features 4.48 (2.40–8.39)
Psychotic features 1.55 (0.81–2.96)
Anxiety symptoms 1.18 (1.08–1.30)
Clinical Global Impression (Severity) 1.84 (1.18–2.87)
Chronic disorder 1.85 (0.96–3.55)
Male sex 0.98 (0.39–32.51)
Inpatient at baseline 1.01 (0.53–1.92)
Ever been admitted for depression 2.20 (0.51–9.52)
Suicide attempts 2.03 (0.74–5.63)
High Neuroticism/Low Extroversion Group 0.71 (0.33–1.82)
Notes: variables found signiﬁcant in the preliminary analysis and those known to inﬂueCox regression analysis (Table 3). In the multivariate Cox analysis
(Table 3), older subjects at baseline and those with depression
with melancholic features had an increased risk for developing
dementia compared to those without melancholic features
(HR¼3.64; 95% C.I. 1.78–11.26). The other depression character-
istics and education were not associated with a higher risk fornd other well established risks for dementia, and the risk of dementia.
Multivariate analysis
p Value HR (95% CI) p Value
1 [reference]
0.002 7.26 (1.99–26.51) 0.003
o0.001 13.18 (3.72–47.50) o0.001
1 [reference]
0.730 1.40 (0.60–3.28) 0.437
0.097 0.461 (0.16–1.34) 0.156
0.116 0.64 (0.22–1.84) 0.408
o0.001 3.64 (1.78–11.26) 0.025
0.182 1.55 (0.76–3.14) 0.224
0.001 0.97 (0.82–1.22) 0.969
0.008 1.19 (0.74–2.36) 0.345
0.065 1.24 (0.58–2.61) 0.581
0.974
0.980
0.290
0.172
0.568
nce the risk for dementia were included in the Cox proporcional hazards models.
Fig. 2. Cumulative incidence of dementia, across the follow-up period, taking into
account the competing risk of death, using a competing-risks regression model.
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Two sensitivity analyses were performed, including age of the
affective disorder (determined in few cases) and vascular risk
factors (data obtained at follow up). In a new model, the inclusion
of age of affective disorder onset and vascular risk factors did not
change the statistical signiﬁcance of the associations between both
melancholic features and age at baseline with dementia risk.
Studies with a very long follow up, especially including ger-
iatric outcomes and depressed patients, are faced with the difﬁcult
problem of how to account for the competing risk of death
(Wulsin et al., 1999). Because Cox proportional hazards regression
can overestimate the risk of disease, a risk competing analysis was
performed. The cumulative incidence of dementia, according to
melancholic features of depression, was higher among subjects
with melancholic features during most of the follow-up period,
reaching approximately 50% at around 30 years of follow-up, ac-
cording to a competitive risk model (Fig. 2).
When comparing melancholic (n¼47, 25 events), non-melan-
cholic depressed patients (n¼86, 19 events) and surgical cohort
subjects (n¼144, 21 events), logistic binary regression analysis
showed a signiﬁcantly increased risk for dementia only in mel-
ancholic subjects when compared to the surgical cohort subjects
(OR¼6.66; 95% C.I. 3.19–13.90 and OR¼7.72; 95% C.I. 3.18–18.77,
for crude and adjusted for baseline age and years of education OR,
respectively). Non-melancholic subjects were not at increased risk
for dementia, in the same analysis (OR¼1.66; 95% C.I. 0.84–3.31
and 2.25; 95% C.I. 0.99–5.10, for crude and adjusted OR,
respectively).
Since the precise age of dementia onset was not possible to
ascertain in about half the subjects from the surgical cohort, Cox
regression analysis was not done in this cohort.4. Discussion
The main ﬁnding of the present study is that melancholic fea-
tures of depression are an important and independent risk factor
for dementia.
Depression has been globally associated with a two-fold in-
crease risk of dementia (Silva et al., 2013), just like we found in this
study. But, as far as we know, melancholic features have not been
previously speciﬁcally assessed as a risk factor for dementia.
Melancholia has been associated with persistent cognitiveimpairment after depression remission (Lin et al., 2014; Roca et al.,
2015), but not with dementia. It is possible that the follow up time
has been too short in both studies (6 weeks and 6 months, re-
spectively) to detect an increased incidence of dementia. Re-
markably, in the present study, melancholic features were in-
dependently associated with dementia. As previously mentioned,
the study from DalForno et al. (2005) failed to ﬁnd an association
of negative affective symptoms with dementia risk. However, the
assessment of negative affective symptoms was based on a CES-D
subscale which does not match exactly the standard criteria for
melancholic features. Most risk factors that have been studied in
previous investigations, such as more severe disorder, greater se-
verity of the episode, diagnosis of bipolar disorder, and the pre-
sence of psychotic and anxious symptoms, were associated with
an increased risk for dementia in the univariate analysis, but their
signiﬁcance disappeared in the multivariate analysis. Since mel-
ancholic features tend to repeat across lifetime episodes (Coryell
et al., 1994), are associated with a more severe course, occur in
virtually all psychotic episodes, and happen more frequently in
bipolar patients (Taylor and Fink, 2008), it is possible that the
higher risk associated with those characteristics in previous stu-
dies could be at least partially mediated by melancholia. However,
the role of bipolar disorder as a risk factor for dementia might have
been underestimated because of the small number of bipolar pa-
tients in the present cohort. Also, non-melancholic subjects were
not found to be at a signiﬁcantly increased risk for dementia,
though results were close to statistical signiﬁcance, despite the
relatively small sample size in this subgroup. In any case, the
present results strongly emphasize that analysis of melancholic
features should be included in future studies.
There is a biological rational for the association between mel-
ancholic features and dementia, as an important body of evidence
pinpoints the biological mechanisms underlying melancholia with
cognitive impairment. Melancholia has been associated with hy-
pothalamus-pituitary-adrenal (HPA) axis dysfunction (Brown,
2007; Parker et al., 2013), and hyper- and hypocortisolism char-
acterize different subtypes of depression (Hasler et al., 2004). This
HPA axis dysfunction has been widely studied in animal models
and in human disorders (Lupien et al., 1998; Finsterwald and Al-
berini, 2013; Suzuki et al., 2014), and involves down regulation of
glucocorticoid receptors and/or increased circulating glucocorti-
coids triggering a cascade of events that leads to cognitive im-
pairment (McEwen and Magariños, 1997; Lupien et al., 2008).
Melancholia may particularly induce hippocampal damage (La-
mers et al., 2013), and has been associated with cognitive decline
(Withall et al., 2010; Sachs-Ericsson et al., 2014).
Present results support a role of depression as an early risk
factor for dementia, and not merely a prodrome. Our results are in
line with studies with a long follow up (Kessing, 1999; Brodaty
et al., 2003; Saczynski et al., 2010; Dotson et al., 2010; Barnes et al.,
2012), with a low probability of misdiagnosing dementia as a
depressive disorder. The few studies that speciﬁcally explored the
differences between early- and late-onset depression found a very
small increased risk for dementia, or no differences in early onset
depression as compared to late-onset depression, however they
assessed depression retrospectively by simply questioning (Green
et al., 2003), using CES-D or Geriatric Depression Scale (Lenoir
et al., 2011; Almeida et al., 2016), or included subjects mainly with
neurotic depression (Brommelhoff et al., 2009). The accuracy of
depression diagnosis was probably lower when compared to the
present study, and this could have led to the inclusion of less se-
vere depressive or non-melancholic patients.
The precise diagnosis of dementia was not possible to ascertain
in about half the cases in the depressed cohort and in about 2/3 of
the controls, a natural consequence of the way clinical information
was collected. So, it was not possible to identify whether
F. Simões do Couto et al. / Journal of Affective Disorders 202 (2016) 220–229 227depressive subtypes were associated with speciﬁc dementing
disorders. It has been suggested that depression is a risk factor
both for vascular dementia (VD) and for Alzheimer's disease (AD)
(Lenoir et al., 2011; Brunnström et al., 2013). The Honolulu-Asia
aging study (Irie et al., 2008) found a higher risk for AD, however a
higher load of cortical plaques and tangles was not associated with
AD and depression (Wilson et al., 2003). Although in half of the
cases the dementia cause could not be identiﬁed, the present re-
sults suggest that depression would be associated essentially with
an increased risk for AD and not VD.
This study has important strengths. It is one of longest long-
itudinal studies performed to evaluate the risk of dementia in
depressed patients. Another strength is that the diagnosis of de-
pression was done very reliably using an extensive and compre-
hensive psychiatric and psychological evaluation. The vast major-
ity of previous studies assessed depression with rather simple
instruments, such as CES-D, that cannot capture the complexity
and heterogeneity of the depressive disorder. Still another strength
is that important and different risk factors and confounders were
assessed (such as personality, severity of the episode, or vascular
risk factors), that have been seldom evaluated together. If different
subtypes of depression carry different risks for dementia, it would
be elicited by a study with this design.
4.1. Limitations
We should also note the limitations of this study. The major
limitation is the large proportion of subjects without follow-up
information, since only 43% of individuals included in the cohorts
had follow-up data. This proportion is high, as compared to case
register based studies with a complete follow-up of data on de-
mentia and death (Kessing et al., 1999; Kessing and Nilsson, 2003).
Attrition may limit the validity of ﬁndings from longitudinal stu-
dies, and is more likely to occur in investigations with long follow-
up periods; however, the latter are essential to evaluate long-term
effects and resemble more closely inception cohorts, which con-
tributes for survival-related biases to be less likely (Saracci, 2006).
Shorter studies evaluate short term effects and often include
predominantly survivors instead of participants selected closer to
the onset of the exposures of interest. Despite the robustness of
our ﬁndings could be improved with a more complete follow-up,
our design allows the evaluation of long-term effects, contributes
to minimize survival-related biases and adds to previous research
on this topic the assessment of the effects of different depression
subtypes. Furthermore, in the present study the completeness of
follow-up was greater than in other similar studies (43% versus, for
instance, 33% in Brodaty et al. (2003)). Melancholia deﬁnition is
controversial, and DSM5 deﬁnition has been challenged, on the
grounds of the limitation of deﬁning melancholia by reliance on
symptoms (Parker and Paterson, 2014). These authors propose the
inclusion of biological markers related to HPA dysfunction. The
inclusion of a biological biomarker would strengthen the ﬁndings
of this study. Another limitation is the absence of a formal cog-
nitive evaluation at baseline. However, dementia was excluded
clinically, the mean age for the onset of the affective disorder was
about 35 years old and the mean time to the event was more than
25 years, making it very unlikely that dementia was present at
baseline.
4.2. Conclusions
This study supports depression as an early risk factor for de-
mentia, and not only a prodrome. Depression is a heterogeneous
disorder, and it is possible that the frequency of melancholic fea-
tures could explain the discrepancies found in the risk for de-
pression as a whole in the different studies. Melancholic featuresof depression should be actively identiﬁed in the clinical setting,
and DSM5 criteria seem appropriate for this purpose. Due to a
more favorable response to biological therapies, appropriate
treatment of melancholia could decrease the risk for dementia.Role of funding source
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